Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04240691 · ClinicalTrials.gov registry record
Instacare - Rapid ART Initiation Among Persons With HIV and Out of Care
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 52
- Enrollment target
NCT04240691: Completed study, sponsored by University of California, San Diego.
NCT04240691 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04240691 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
This study aims to evaluate two ways to help people re-engage with healthcare. The first is to assess if providing HIV treatment on the first visit (or within 1 week) can help people re-engage with care and ultimately stay in care after 24 and 48 weeks. It will also assess the success of starting treatment immediately by measuring the HIV virus in people's bloodstream after 24 and 48 weeks. The second part of this study is to assess a new behavioral treatment called 60-Minutes-for-Health which aims to help people identify and overcome barriers to HIV care, to help with motivation maintaining in care, to help cope with negative feelings about HIV, and to help increase self-reliance in seeking healthcare amid other things that are happening in your life.
Primary Outcome
HIV VL ≤50 at week 24
Interventions
- BEHAVIORAL 60-Minutes-For-Health
- OTHER Time-and-Attention Control Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2020-05-20 |
| Est. Completion | 2024-04-05 |
What the finished NCT04240691 record still lists
NCT04240691 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which 60-Minutes-For-Health is the first listed.
NCT04240691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04240691 about?
NCT04240691 is a clinical study titled "Instacare - Rapid ART Initiation Among Persons With HIV and Out of Care". This study aims to evaluate two ways to help people re-engage with healthcare. The first is to assess if providing HIV treatment on the first visit (or within 1 week) can help people re-engage with care and ultimately stay in care after 24 and 48 weeks. It will also assess the success of starting tr...
What is the current status of trial NCT04240691?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2020-05-20. Estimated completion is 2024-04-05.
What interventions are being tested in trial NCT04240691?
The interventions under investigation include: 60-Minutes-For-Health (BEHAVIORAL), Time-and-Attention Control Session (OTHER).
Who is sponsoring clinical trial NCT04240691?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI